Insulet Pops As Diabetes Medtech Continues Its Streak Of 'Impressive Beat-And-Raises'Investors Business Daily • 08/07/25
Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency1)Business Wire • 08/07/25
Curious about Insulet (PODD) Q2 Performance? Explore Wall Street Estimates for Key MetricsZacks Investment Research • 08/05/25
10 stocks favored to gain up to 30% in a sector that has missed this year's rallyMarket Watch • 07/31/25
15 stocks of companies set to grow sales twice as fast as the S&P 500 — analysts love themMarket Watch • 07/21/25
Will Insulet (PODD) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research • 07/09/25
Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific SessionsBusiness Wire • 06/19/25
Insulet's Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. UsersBusiness Wire • 06/10/25
20 stocks of companies that have improved profit margins and are expected to grow quicklyMarket Watch • 06/09/25
Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025Business Wire • 05/23/25
20 stocks of companies showing excellent earnings-season trends even as the economy coolsMarket Watch • 05/12/25
Insulet Q1 Earnings Top Estimates, Stock Up, 2025 Sales View RaisedZacks Investment Research • 05/12/25